Vanta Bioscience Limited Share Price

BSE: 540729
|
Diversified

₹ 20.42

+0.00 (0.00%)
1D
Last updated 06 Oct, 2026, 09:46 IST
--
0.00% up today
--
1D LOW
1D HIGH

Vanta Bioscience Limited Returns Calculator

Volume
--
Average traded price
--
Last traded time
09:46:30 06 Oct
Last traded quantity
1,500
Circuit
L
H
₹18.38
₹22.46
52-week
L
H
₹14.71
₹29.00
Mkt Cap Cr
14.52
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vanta Bioscience outperforming all market indices
Step 3 of 5
Earnings
Neutral
Vanta Bioscience earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,12,225.3652.1211.949.79%20.48%17.27%0.9828.14
MANIPAL HEALTH ENTERPRI L87,860.6296.945.354.07%10.59%9.51%1.1735.11
Max Healthcare84,580.6657.687.828.46%13.42%12.97%0.8435.73
Aster DM Healthcare59,426.27165.6314.284.47%8.48%10.1%1.966.42
Fortis Healthcare57,074.8453.315.776.7%10.53%12.56%0.827.65
Global Health35,176.8962.378.79.35%14.05%15.26%2.5433.32
Narayana Hrudayalaya34,465.4542.27.596.55%17.76%11.42%2.0721.3
Dr. Lal Path Labs32,084.3058.7312.7917.36%20.13%25.56%3.3835.44
KRISHNA INST OF MED SCI L29,767.96153.087.942.51%10.74%7.99%0.6839.22
Poly Medicure16,207.7051.85.227.99%10.37%12.71%2.6229.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Vanta Bioscience Limited

ISIN
INE695X01011
Sector Market Cap
₹ 14.52 Cr

Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The Company has investments in one of its subsidiaries, Vantaclinical Research Limited.

Vanta Bioscience Limited Financial Highlights

  • Revenue: Vanta Bioscience Limited reported revenue of ₹1.98 crore in FY26 vs ₹1.17 crore in FY25. It showed an increase of 69.23% on a yearly basis.
  • Operating Profit: Vanta Bioscience Limited reported an operating profit of ₹0.01 crore in FY26 vs ₹2.73 crore in FY25. It showed an increase of 100.37% on a year-on-year basis.
  • Net Profit: Vanta Bioscience Limited reported a net profit of ₹0.11 crore in FY26 vs ₹2.67 crore in FY25. It showed an increase of 104.12% on a yearly basis.
Know more
Promoters
72.81%
FII
0.00%
Other DII
0.00%
Retail and other
27.19%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20250.00%
Jun 20250.00%
Sep 20250.00%
Mar 20260.00%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
06 Oct 26
₹20.42 / ₹20.42
0.00%
05 Oct 26
₹20.50 / ₹20.42
-4.98%
01 Oct 26
₹21.50 / ₹21.49
-5.00%
30 Sep 26
₹22.22 / ₹22.62
+4.97%
Show more

Vanta Bioscience Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1.96₹9.72₹6.28₹9.69
Other Income₹0.11₹0.11₹0.69₹0.42
Total Revenue₹2.07₹9.83₹6.96₹10.11
Total Expenses₹14.70₹18.66₹17.23₹9.88
Profit Before Tax-₹12.63-₹8.83-₹10.26₹0.23
Tax₹0.66-₹0.22₹0.18₹0.09
Profit After Tax-₹13.29-₹8.61-₹10.44₹0.13
EPS - Basic-₹7.56-₹3.67-₹10.27₹0.14
EPS - Diluted-₹7.56-₹3.67-₹10.27₹0.14

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax-₹8.83-₹10.26₹0.23₹0.59
Income before WC changes₹1.38-₹1.71₹3.89₹3.96
Change in Assets-₹1.76-₹0.21₹1.69₹2.46
Change in Liabilities₹3.07₹1.29-₹0.30₹0.55
Change in WC₹1.31₹1.08₹1.39₹3.01
Cash flow from Operations₹2.68-₹0.63₹5.28₹6.97
Cash flow from Investing-₹3.31-₹5.91-₹17.18-₹22.19
Cash flow from Financing₹0.69₹6.41₹9.53₹17.78
Total Cash Flow₹0.06-₹0.13-₹2.43₹2.46
Cash (Start of the year)₹0.10₹0.22₹2.65₹0.20
Cash (End of the year)₹0.16₹0.10₹0.22₹2.65

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹70.52₹68.24₹69.47₹66.91
Current Assets₹15.36₹17.16₹15.24₹14.50
Total Assets₹85.88₹85.40₹84.71₹81.40
Current Liabilities₹26.56₹22.79₹17.75₹17.76
Net Current Asset-₹11.21-₹5.62-₹2.50-₹3.26
Non-Current Liabilities₹55.53₹49.64₹48.03₹34.30
Equity Capital₹3.78₹12.97₹18.93₹29.34
Total Equity & Liabilities₹85.88₹85.40₹84.71₹81.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1.13₹8.56₹5.17₹9.35
Other Income₹0.04₹0.05₹0.63₹0.17
Total Revenue₹1.17₹8.61₹5.80₹9.52
Total Expenses₹3.89₹8.56₹10.00₹9.38
Profit Before Tax-₹2.72₹0.04-₹4.21₹0.14
Tax-₹0.06-₹0.01₹0.03₹0.06
Profit After Tax-₹2.66₹0.05-₹4.24₹0.08
EPS - Basic-₹4.21₹0.08-₹6.71₹0.12
EPS - Diluted-₹4.21₹0.08-₹6.71₹0.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax₹0.04-₹4.21₹0.14₹0.61
Income before WC changes₹3.66₹0.15₹3.57₹3.89
Change in Assets-₹0.72₹0.03₹2.61₹4.04
Change in Liabilities₹1.61₹0.47₹0.52₹3.07
Change in WC₹0.89₹0.49₹3.13₹7.11
Cash flow from Operations₹4.55₹0.64₹6.70₹11.01
Cash flow from Investing-₹1.67-₹2.53-₹8.05-₹9.86
Cash flow from Financing-₹2.81₹1.88₹1.38-₹1.07
Total Cash Flow₹0.07₹0.00₹0.00-₹0.02
Cash (Start of the year)₹0.07₹0.07₹0.07₹0.09
Cash (End of the year)₹0.14₹0.07₹0.07₹0.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹45.44₹40.88₹40.51₹39.40
Current Assets₹10.39₹12.03₹11.13₹11.00
Total Assets₹55.84₹52.91₹51.64₹50.40
Current Liabilities₹18.57₹14.20₹10.25₹9.98
Net Current Asset-₹8.18-₹2.18₹0.89₹1.02
Non-Current Liabilities₹20.13₹18.91₹21.65₹16.43
Equity Capital₹17.13₹19.79₹19.74₹23.99
Total Equity & Liabilities₹55.84₹52.91₹51.64₹50.40
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
20.41
750
20.42
1500
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2250
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.36
Neutral
ATR (14)
1.05
Neutral
STOCH(9,6)
45.41
Neutral
STOCH RSI (14)
56.47
Neutral
ADX(9)
26.71
Bearish
UO(9)
46.37
Neutral
ROC(12)
-10.56
Bearish
WillR(14)
-56.84
Neutral
Period
Simple value
Exponential vaue
5D
21.3
20.87
10D
20.64
21.12
20D
22.19
21.54
50D
20.99
21.4
100D
20.75
22.19

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vanta Bioscience Limited
Diversified
Add Stock
Add Another

Vanta Bioscience Limited Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.